Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 409 for breast cancer

Edit search filters
  1. Safety Study Of Nivolumab With Nab-Paclitaxel Plus Or Minus Gemcitabine In Pancreatic Cancer, Nab-Paclitaxel / Carboplatin In Stage IIIB/IV Non-Small Cell Lung Cancer Or Nab-Paclitaxel In Recurrent Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ

  2. Carboplatin And Paclitaxel With Or Without Atezolizumab Before Surgery In Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate T-DM1 With Or Without Abemaciclib In Women And Men With HER2-positive Advanced Or Metastatic Breast Cancer

    Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer

    Jacksonville, FL

  6. Safety And Efficacy Study Of MLN0128 In Combination With Exemestane Or Fulvestrant In Postmenopausal Women With ER/PR+ Metastatic Breast Cancer

    Rochester, MN

  7. Alisertib And Fulvestrant In Treating Patients With Hormone Receptor Positive Breast Cancer That Is Metastatic Or Locally Advanced And Cannot Be Removed By Surgery

    Rochester, MN

  8. Nemvaleukin Alfa (ALKS 4230) Monotherapy In Patients With Advanced Cutaneous Melanoma Or Advanced Mucosal Melanoma

    Jacksonville, FL, Rochester, MN

  9. A Study To Compare Conventional Heart Echo Measurements With Newer 2 And 3 Dimensional Measurements Of Mechanical Heart Strain After Trastuzumab Infusion

    Rochester, MN

  10. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer